SPTXSeaport Therapeutics, Inc.

Healthcare
$18.14

The financials

Seaport Therapeutics, Inc. by the numbers

The next results filing is expected around Nov 2, 2026, a quarter after the last one.

Seaport Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$66M−$16Mn/a
Net income−$63M−$13Mn/a
Diluted EPS−$1.78−$5.65n/a

Biotechnology

The closest names by size in the same industry

Compare peers
VOR+3.9%
Vor Biopharma Inc.
LXRX-4.6%
Lexicon Pharmaceuticals, Inc.
DRTS+2.8%
Alpha Tau Medical Ltd.
MGTX+1.9%
MeiraGTx Holdings plc
REPL+3.0%
Replimune Group, Inc.
ANL+0.77%
Adlai Nortye Ltd.